Nonsurgical Management of Knee, Hip, and Polyarticular Osteoarthritis Clinical Practice Guidelines (2019)

Osteoarthritis Research Society International (OARSI)

This is a quick summary of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

July 30, 2019

The guidelines on nonsurgical management of knee, hip, and polyarticular osteoarthritis (OA) were released on July 3, 2019, by the Osteoarthritis Research Society International (OARSI).[1]

Core treatments for knee OA include arthritis education and structured land-based exercise programs with or without dietary weight management.

Core treatments for hip and polyarticular OA include arthritis education and structured land-based exercise programs.

Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are strongly recommended for individuals with knee OA.

For individuals with gastrointestinal comorbidities, the use of cyclooxygenase (COX)-2 inhibitors or NSAIDs with proton pump inhibitors (PPIs) is recommended.

For individuals with cardiovascular comorbidities or frailty, the use of any oral NSAID is not recommended.

Intra-articular (IA) corticosteroids, IA hyaluronic acid, and aquatic exercise are recommended for knee OA, depending upon comorbidity status, but are not recommended for individuals with hip or polyarticular OA.

The use of acetaminophen (paracetamol) is conditionally not recommended.

The use of oral and transdermal opioids is strongly not recommended.

For more information, please go to Osteoarthritis.

For more Clinical Practice Guidelines, please go to Guidelines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: